Abstract
Granulocyte transfusion therapy has been used as an adjunct to broad spectrum antibiotics in the management of serious infections in granulocytopenic patients. This treatment is based upon the observation that the incidence of infection is inversely related to the absolute granulocyte count in granulocytopenic patients and upon the demonstrated value of replacement therapy of other blood cell components such as platelets for thrombocytopenia. In addition, the occurrence of dramatic clinical improvement frequently noted with only small increases in granulocyte count as the marrow begins to regenerate suggests that transfusions of granulocytes should be of benefit.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
